Skip to main content
SpringerLink
Log in

Echocardiography for the Management of End Stage Ischemic Heart Disease and as a Tool for Resynchronization Therapy

  • Chapter
  • First Online:
Echocardiography in Acute Coronary Syndrome

  • 1252 Accesses

This chapter will discuss: (1) the clinical uses of echocardiography in HF after acute coronary syndrome and its prognostic value; (2) the use of echocardiography to guide treatment in HF patients; and (3) promising future techniques for echocardiographic-based imaging in HF. In addition, we will highlight some of the limitations of echocardiography.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112:e154–e235.

    Article  PubMed  Google Scholar 

  2. American Heart Association ASA. Heart disease and stroke statistics: 2005 update. Available at: http://www.americanheart.org/downloadable/heart/1072969766940HSStats2004Update.pdf

  3. Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106:3068–3072.

    Article  PubMed  Google Scholar 

  4. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 1993;88:107–115.

    PubMed  CAS  Google Scholar 

  5. Capomolla S, Ceresa M, Pinna G, et al. Echo-Doppler and clinical evaluations to define hemodynamic profile in patients with chronic heart failure: accuracy and influence on therapeutic management. Eur J Heart Fail. 2005;7:624–630.

    Article  PubMed  Google Scholar 

  6. Badgett RG, Lucey CR, Mulrow CD. Can the clinical examination diagnose left-sided heart failure in adults? JAMA. 1997;277:1712–1719.

    Article  PubMed  CAS  Google Scholar 

  7. Nagueh SF, Kopelen HA, Zoghbi WA. Relation of mean right atrial pressure to echocardiographic and Doppler parameters of right atrial and right ventricular function. Circulation. 1996;93:1160–1169.

    PubMed  CAS  Google Scholar 

  8. Masuyama T, Kodama K, Kitabatake A, Sato H, Nanto S, Inoue M. Continuous-wave Doppler echocardiographic detection of pulmonary regurgitation and its application to noninvasive estimation of pulmonary artery pressure. Circulation. 1986;74:484–492.

    Article  PubMed  CAS  Google Scholar 

  9. Berger M, Haimowitz A, Van Tosh A, Berdoff RL, Goldberg E. Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. J Am Coll Cardiol. 1985;6:359–365.

    Article  PubMed  CAS  Google Scholar 

  10. Sorrell VL, Reeves WC. Noninvasive right and left heart catheterization: taking the echo lab beyond an image-only laboratory. Echocardiography. 2001;18:31–41.

    Article  PubMed  CAS  Google Scholar 

  11. Franklin KM, Aurigemma GP. Prognosis in diastolic heart failure. Prog Cardiovasc Dis. 2005;47:333–339.

    Article  PubMed  Google Scholar 

  12. Aurigemma GP, Gottdiener JS, Shemanski L, Gardin J, Kitzman D. Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the cardiovascular health study. J Am Coll Cardiol. 2001;37:1042–1048.

    Article  PubMed  CAS  Google Scholar 

  13. Nagueh SF. Noninvasive evaluation of hemodynamics by Doppler echocardiography. Curr Opin Cardiol. 1999;14:217–224.

    Article  PubMed  CAS  Google Scholar 

  14. Ommen SR, Nishimura RA, Appleton CP, et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation. 2000;102:1788–1794.

    PubMed  CAS  Google Scholar 

  15. Pinamonti B, Zecchin M, Di Lenarda A, Gregori D, Sinagra G, Camerini F. Persistence of restrictive left ventricular filling pattern in dilated cardiomyopathy: an ominous prognostic sign. J Am Coll Cardiol. 1997;29:604–612.

    Article  PubMed  CAS  Google Scholar 

  16. Dini FL, Dell’Anna R, Micheli A, Michelassi C, Rovai D. Impact of blunted pulmonary venous flow on the outcome of patients with left ventricular systolic dysfunction secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 2000;85:1455–1460.

    Article  PubMed  CAS  Google Scholar 

  17. Garcia MJ, Smedira NG, Greenberg NL, et al. Color M-mode Doppler flow propagation velocity is a preload insensitive index of left ventricular relaxation: animal and human validation. J Am Coll Cardiol. 2000;35:201–208.

    Article  PubMed  CAS  Google Scholar 

  18. Garcia MJ, Ares MA, Asher C, Rodriguez L, Vandervoort P, Thomas JD. An index of early left ventricular filling that combined with pulsed Doppler peak E velocity may estimate capillary wedge pressure. J Am Coll Cardiol. 1997;29:448–454.

    Article  PubMed  CAS  Google Scholar 

  19. Takemoto Y, Barnes ME, Seward JB, et al. Usefulness of left atrial volume in predicting first congestive heart failure in patients > or = 65 years of age with well-preserved left ventricular systolic function. Am J Cardiol. 2005;96:832–836.

    Google Scholar 

  20. Rossi A, Loredana L, Cicoira M, et al. Additional value of pulmonary vein parameters in defining pseudonormalization of mitral inflow pattern. Echocardiography. 2001;18: 673–679.

    Article  PubMed  CAS  Google Scholar 

  21. Mottram PM, Leano R, Marwick TH. Usefulness of B-type natriuretic peptide in hypertensive patients with exertional dyspnea and normal left ventricular ejection fraction and correlation with new echocardiographic indexes of systolic and diastolic function. Am J Cardiol. 2003;92:1434–1438.

    Article  PubMed  CAS  Google Scholar 

  22. Dokainish H, Zoghbi WA, Lakkis NM, Quinones MA, Nagueh SF. Comparative accuracy of B-type natriuretic peptide and tissue Doppler echocardiography in the diagnosis of congestive heart failure. Am J Cardiol. 2004;93:1130–1135.

    Article  PubMed  CAS  Google Scholar 

  23. Kirkpatrick JN, Vannan MA, Narula J, Lang RM. Echocardiography in heart failure: applications, utility, and new horizons. J Am Coll Cardiol. 2007;50:381–396.

    Article  PubMed  Google Scholar 

  24. Schillaci G, Pasqualini L, Verdecchia P, et al. Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. J Am Coll Cardiol. 2002;39:2005–2011.

    Article  PubMed  Google Scholar 

  25. Bella JN, Palmieri V, Roman MJ, et al. Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: the Strong Heart Study. Circulation. 2002;105:1928–1933.

    Article  PubMed  Google Scholar 

  26. Temporelli PL, Giannuzzi P, Nicolosi GL, et al. Doppler-derived mitral deceleration time as a strong prognostic marker of left ventricular remodeling and survival after acute myocardial infarction: results of the GISSI-3 echo substudy. J Am Coll Cardiol. 2004;43:1646–1653.

    Article  PubMed  Google Scholar 

  27. Pinamonti B, Di Lenarda A, Sinagra G, Camerini F. Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by Doppler echocardiography: clinical, echocardiographic and hemodynamic correlations and prognostic implications. Heart Muscle Disease Study Group. J Am Coll Cardiol. 1993;22:808–815.

    Article  PubMed  CAS  Google Scholar 

  28. Florea VG, Henein MY, Cicoira M, et al. Echocardiographic determinants of mortality in patients >67 years of age with chronic heart failure. Am J Cardiol. 2000;86:158–161.

    Article  PubMed  CAS  Google Scholar 

  29. Hillis GS, Moller JE, Pellikka PA, et al. Noninvasive estimation of left ventricular filling pressure by E/E′ is a powerful predictor of survival after acute myocardial infarction. J Am Coll Cardiol. 2004;43:360–367.

    Article  PubMed  Google Scholar 

  30. Hamdan A, Shapira Y, Bengal T, et al. Tissue Doppler imaging in patients with advanced heart failure: relation to functional class and prognosis. J Heart Lung Transplant. 2006;25:214–218.

    Article  PubMed  Google Scholar 

  31. Acil T, Wichter T, Stypmann J, et al. Prognostic value of tissue Doppler imaging in patients with chronic congestive heart failure. Int J Cardiol. 2005;103:175–181.

    Article  PubMed  Google Scholar 

  32. Dokainish H, Zoghbi WA, Lakkis NM, et al. Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure. J Am Coll Cardiol. 2005;45:1223–1226.

    Article  PubMed  CAS  Google Scholar 

  33. Nikitin NP, Loh PH, Silva R, et al. Prognostic value of systolic mitral annular velocity measured with Doppler tissue imaging in patients with chronic heart failure caused by left ventricular systolic dysfunction. Heart. 2006;92:775–779.

    Article  PubMed  CAS  Google Scholar 

  34. Moller JE, Sondergaard E, Poulsen SH, Seward JB, Appleton CP, Egstrup K. Color M-mode and pulsed wave tissue Doppler echocardiography: powerful predictors of cardiac events after first myocardial infarction. J Am Soc Echocardiogr. 2001;14:757–763.

    Article  PubMed  CAS  Google Scholar 

  35. Moller JE, Sondergaard E, Poulsen SH, Appleton CP, Egstrup K. Serial Doppler echocardiographic assessment of left and right ventricular performance after a first myocardial infarction. J Am Soc Echocardiogr. 2001;14:249–255.

    Article  PubMed  CAS  Google Scholar 

  36. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study. Circulation. 2004;109:3176–3181.

    Article  PubMed  CAS  Google Scholar 

  37. Hansen A, Haass M, Zugck C, et al. Prognostic value of Doppler echocardiographic mitral inflow patterns: implications for risk stratification in patients with chronic congestive heart failure. J Am Coll Cardiol. 2001;37:1049–1055.

    Article  PubMed  CAS  Google Scholar 

  38. Traversi E, Pozzoli M, Cioffi G, et al. Mitral flow velocity changes after 6 months of optimized therapy provide important hemodynamic and prognostic information in patients with chronic heart failure. Am Heart J. 1996;132:809–819.

    Article  PubMed  CAS  Google Scholar 

  39. Xie GY, Berk MR, Smith MD, Gurley JC, DeMaria AN. Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure. J Am Coll Cardiol. 1994;24:132–139.

    Article  PubMed  CAS  Google Scholar 

  40. Bruch C, Gotzmann M, Stypmann J, et al. Electrocardiography and Doppler echocardiography for risk stratification in patients with chronic heart failure: incremental prognostic value of QRS duration and a restrictive mitral filling pattern. J Am Coll Cardiol. 2005;45: 1072–1075.

    Article  PubMed  Google Scholar 

  41. Klein AL, Hatle LK, Taliercio CP, et al. Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study. Circulation. 1991;83:808–816.

    PubMed  CAS  Google Scholar 

  42. Whalley GA, Doughty RN, Gamble GD, et al. Pseudonormal mitral filling pattern predicts hospital re-admission in patients with congestive heart failure. J Am Coll Cardiol. 2002;39:1787–1795.

    Article  PubMed  Google Scholar 

  43. Tei C, Ling LH, Hodge DO, et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function – a study in normals and dilated cardiomyopathy. J Cardiol. 1995;26:357–366.

    PubMed  CAS  Google Scholar 

  44. Spencer KT, Kirkpatrick JN, Mor-Avi V, Decara JM, Lang RM. Age dependency of the Tei index of myocardial performance. J Am Soc Echocardiogr. 2004;17:350–352.

    Article  PubMed  Google Scholar 

  45. Tei C, Nishimura RA, Seward JB, Tajik AJ. Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements. J Am Soc Echocardiogr. 1997;10:169–178.

    Article  PubMed  CAS  Google Scholar 

  46. Yeo TC, Dujardin KS, Tei C, Mahoney DW, McGoon MD, Seward JB. Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension. Am J Cardiol. 1998;81:1157–1161.

    Article  PubMed  CAS  Google Scholar 

  47. Dujardin KS, Tei C, Yeo TC, Hodge DO, Rossi A, Seward JB. Prognostic value of a Doppler index combining systolic and diastolic performance in idiopathic-dilated cardiomyopathy. Am J Cardiol. 1998;82:1071–1076.

    Article  PubMed  CAS  Google Scholar 

  48. Arnlov J, Ingelsson E, Riserus U, Andren B, Lind L. Myocardial performance index, a Doppler-derived index of global left ventricular function, predicts congestive heart failure in elderly men. Eur Heart J. 2004;25:2220–2225.

    Article  PubMed  Google Scholar 

  49. Mikkelsen KV, Moller JE, Bie P, Ryde H, Videbaek L, Haghfelt T. Tei index and neurohormonal activation in patients with incident heart failure: serial changes and prognostic value. Eur J Heart Fail. 2006;8:599–608.

    Article  PubMed  CAS  Google Scholar 

  50. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440–1463.

    Article  PubMed  Google Scholar 

  51. Malm S, Frigstad S, Sagberg E, Larsson H, Skjaerpe T. Accurate and reproducible measurement of left ventricular volume and ejection fraction by contrast echocardiography: a comparison with magnetic resonance imaging. J Am Coll Cardiol. 2004;44:1030–1035.

    Google Scholar 

  52. Hundley WG, Kizilbash AM, Afridi I, Franco F, Peshock RM, Grayburn PA. Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging. J Am Coll Cardiol. 1998;32:1426–1432.

    Article  PubMed  CAS  Google Scholar 

  53. Yu EH, Sloggett CE, Iwanochko RM, Rakowski H, Siu SC. Feasibility and accuracy of left ventricular volumes and ejection fraction determination by fundamental, tissue harmonic, and intravenous contrast imaging in difficult-to-image patients. J Am Soc Echocardiogr. 2000;13:216–224.

    PubMed  CAS  Google Scholar 

  54. Spencer KT, Bednarz J, Rafter PG, Korcarz C, Lang RM. Use of harmonic imaging without echocardiographic contrast to improve two-dimensional image quality. Am J Cardiol. 1998;82:794–799.

    Article  PubMed  CAS  Google Scholar 

  55. Lang RM, Mor-Avi V, Zoghbi WA, Senior R, Klein AL, Pearlman AS. The role of contrast enhancement in echocardiographic assessment of left ventricular function. Am J Cardiol. 2002;90:28 J–34 J.

    Article  Google Scholar 

  56. Bellenger NG, Burgess MI, Ray SG, et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur Heart J. 2000;21: 1387–1396.

    Article  PubMed  CAS  Google Scholar 

  57. Jacobs LD, Salgo IS, Goonewardena S, et al. Rapid online quantification of left ventricular volume from real-time three-dimensional echocardiographic data. Eur Heart J. 2006;27:460–468.

    Google Scholar 

  58. Cohen-Solal A, Tabet JY, Logeart D, Bourgoin P, Tokmakova M, Dahan M. A non-invasively determined surrogate of cardiac power (‘circulatory power’) at peak exercise is a powerful prognostic factor in chronic heart failure. Eur Heart J. 2002;23:806–814.

    Article  PubMed  CAS  Google Scholar 

  59. Smart N, Haluska B, Leano R, Case C, Mottram PM, Marwick TH. Determinants of functional capacity in patients with chronic heart failure: role of filling pressure and systolic and diastolic function. Am Heart J. 2005;149:152–158.

    Article  PubMed  Google Scholar 

  60. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol. 1999;33:1948–1955.

    Article  PubMed  CAS  Google Scholar 

  61. Wong M, Staszewsky L, Latini R, et al. Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure: Valsartan heart failure trial (Val-HeFT) echocardiographic data. J Am Coll Cardiol. 2004;43:2022–2027.

    Article  PubMed  Google Scholar 

  62. Grayburn PA, Appleton CP, DeMaria AN, et al. Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure: the Beta-blocker Evaluation of Survival Trial (BEST). J Am Coll Cardiol. 2005;45:1064–1071.

    Article  PubMed  Google Scholar 

  63. Sanz G, Castaner A, Betriu A, et al. Determinants of prognosis in survivors of myocardial infarction: a prospective clinical angiographic study. N Engl J Med. 1982;306:1065–1070.

    Article  PubMed  CAS  Google Scholar 

  64. Risk stratification and survival after myocardial infarction. N Engl J Med. 1983;309:331–336

    Google Scholar 

  65. Ahnve S, Gilpin E, Henning H, Curtis G, Collins D, Ross J Jr. Limitations and advantages of the ejection fraction for defining high risk after acute myocardial infarction. Am J Cardiol. 1986;58:872–878.

    Article  PubMed  CAS  Google Scholar 

  66. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76:44–51.

    Google Scholar 

  67. St John Sutton M, Pfeffer MA, Plappert T, et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation. 1994;89:68–75.

    PubMed  CAS  Google Scholar 

  68. Cleland JG, Torabi A, Khan NK. Epidemiology and management of heart failure and left ventricular systolic dysfunction in the aftermath of a myocardial infarction. Heart. 2005;91(suppl 2):ii7–ii13; discussion ii31, ii43–ii48.

    Article  PubMed  Google Scholar 

  69. Burns RJ, Gibbons RJ, Yi Q, et al. The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol. 2002;39: 30–36.

    Google Scholar 

  70. Marchioli R, Avanzini F, Barzi F, et al. Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations: GISSI-Prevenzione mortality risk chart. Eur Heart J. 2001;22:2085–2103.

    Article  PubMed  CAS  Google Scholar 

  71. Cooper RS, Simmons BE, Castaner A, Santhanam V, Ghali J, Mar M. Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed. Am J Cardiol. 1990;65:441–445.

    Article  PubMed  CAS  Google Scholar 

  72. Quinones MA, Greenberg BH, Kopelen HA, et al. Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol. 2000;35:1237–1244.

    Article  PubMed  CAS  Google Scholar 

  73. Yancy CW. Heart failure in African Americans. Am J Cardiol. 2005;96:3i–12i.

    Article  PubMed  Google Scholar 

  74. Park SH, Shub C, Nobrega TP, Bailey KR, Seward JB. Two-dimensional echocardiographic calculation of left ventricular mass as recommended by the American Society of Echocardiography: correlation with autopsy and M-mode echocardiography. J Am Soc Echocardiogr. 1996;9:119–128.

    Article  PubMed  CAS  Google Scholar 

  75. Devereux RB, de Simone G, Ganau A, Roman MJ. Left ventricular hypertrophy and geometric remodeling in hypertension: stimuli, functional consequences and prognostic implications. J Hypertens Suppl. 1994;12:S117–S127.

    PubMed  CAS  Google Scholar 

  76. Chaudhry FA, Tauke JT, Alessandrini RS, Vardi G, Parker MA, Bonow RO. Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol. 1999;34:730–738.

    Article  PubMed  CAS  Google Scholar 

  77. Galatro K, Chaudhry FA. Prognostic implications of myocardial contractile reserve in patients with ischemic cardiomyopathy. Echocardiography. 2000;17:61–67.

    Article  PubMed  CAS  Google Scholar 

  78. Chaudhry FA, Singh B, Galatro K. Reversible left ventricular dysfunction. Echocardiography. 2000;17:495–506.

    Article  PubMed  CAS  Google Scholar 

  79. Edner M, Bonarjee VV, Nilsen DW, Berning J, Carstensen S, Caidahl K. Effect of enalapril initiated early after acute myocardial infarction on heart failure parameters, with reference to clinical class and echocardiographic determinants. CONSENSUS II Multi-Echo Study Group. Clin Cardiol. 1996;19:543–548.

    Article  PubMed  CAS  Google Scholar 

  80. Vantrimpont P, Rouleau JL, Wun CC, et al. Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators. J Am Coll Cardiol. 1997;29:229–236.

    Article  PubMed  CAS  Google Scholar 

  81. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001–2007

    Google Scholar 

  82. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709–717.

    Article  PubMed  CAS  Google Scholar 

  83. Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348: 1309–1321.

    Article  PubMed  CAS  Google Scholar 

  84. Australia/New Zealand Heart Failure Research Collaborative Group. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet. 1997;349:375–380

    Google Scholar 

  85. Youssef G, Links M. The prevention and management of cardiovascular complications of chemotherapy in patients with cancer. Am J Cardiovasc Drugs. 2005;5:233–243.

    Article  PubMed  CAS  Google Scholar 

  86. Tassan-Mangina S, Codorean D, Metivier M, et al. Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: early and late alterations of left ventricular function during a prospective study. Eur J Echocardiogr. 2006;7:141–146.

    Article  PubMed  Google Scholar 

  87. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346: 877–883.

    Article  PubMed  Google Scholar 

  88. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–237.

    Article  PubMed  CAS  Google Scholar 

  89. Hohnloser SH, Kuck KH, Dorian P, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481–2488.

    Article  PubMed  CAS  Google Scholar 

  90. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350: 2140–2150.

    Article  PubMed  CAS  Google Scholar 

  91. Achilli A, Sassara M, Ficili S, et al. Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and “narrow” QRS. J Am Coll Cardiol. 2003;42:2117–2124.

    Article  PubMed  Google Scholar 

  92. Pitzalis MV, Iacoviello M, Romito R, et al. Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J Am Coll Cardiol. 2002;40: 1615–1622.

    Article  PubMed  Google Scholar 

  93. Stellbrink C, Breithardt OA, Franke A, et al. Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances. J Am Coll Cardiol. 2001;38:1957–1965.

    Article  PubMed  CAS  Google Scholar 

  94. Yu CM, Bleeker GB, Fung JW, et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation. 2005;112:1580–1586.

    Article  PubMed  Google Scholar 

  95. Bax JJ, Ansalone G, Breithardt OA, et al. Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use? A critical appraisal. J Am Coll Cardiol. 2004;44:1–9.

    Article  PubMed  Google Scholar 

  96. Yu CM, Abraham WT, Bax J, et al. Predictors of response to cardiac resynchronization therapy (PROSPECT) – study design. Am Heart J. 2005;149:600–605.

    Article  PubMed  Google Scholar 

  97. Nesta F, Otsuji Y, Handschumacher MD, et al. Leaflet concavity: a rapid visual clue to the presence and mechanism of functional mitral regurgitation. J Am Soc Echocardiogr. 2003;16:1301–1308.

    Article  PubMed  Google Scholar 

  98. Kwan J, Shiota T, Agler DA, et al. Geometric differences of the mitral apparatus between ischemic and dilated cardiomyopathy with significant mitral regurgitation: real-time three-dimensional echocardiography study. Circulation. 2003;107:1135–1140.

    Article  PubMed  Google Scholar 

  99. Bolling SF, Pagani FD, Deeb GM, Bach DS. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg. 1998;115:381–386.; discussion 387–388.

    Article  PubMed  CAS  Google Scholar 

  100. Breithardt OA, Sinha AM, Schwammenthal E, et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol. 2003;41:765–770.

    Article  PubMed  Google Scholar 

  101. Jimenez JH, Soerensen DD, He Z, He S, Yoganathan AP. Effects of a saddle shaped annulus on mitral valve function and chordal force distribution: an in vitro study. Ann Biomed Eng. 2003;31:1171–1181.

    Article  PubMed  Google Scholar 

  102. Khanna D, Miller AP, Nanda NC, Ahmed S, Lloyd SG. Transthoracic and transesophageal echocardiographic assessment of mitral regurgitation severity: usefulness of qualitative and semiquantitative techniques. Echocardiography. 2005;22:748–769.

    Article  PubMed  Google Scholar 

  103. Quere JP, Tribouilloy C, Enriquez-Sarano M. Vena contracta width measurement: theoretic basis and usefulness in the assessment of valvular regurgitation severity. Curr Cardiol Rep. 2003;5:110–115.

    Article  PubMed  Google Scholar 

  104. Athanasuleas CL, Stanley AW, Buckberg GD, Dor V, Di Donato M, Siler W. Surgical anterior ventricular endocardial restoration (SAVER) for dilated ischemic cardiomyopathy. Semin Thorac Cardiovasc Surg. 2001;13:448–458.

    PubMed  CAS  Google Scholar 

  105. Suma H, Isomura T, Horii T, et al. Nontransplant cardiac surgery for end-stage cardiomyopathy. J Thorac Cardiovasc Surg. 2000;119:1233–1244.

    Article  PubMed  CAS  Google Scholar 

  106. Wilhelm MJ, Hammel D, Schmid C, et al. Partial left ventriculectomy and mitral valve repair: favorable short-term results in carefully selected patients with advanced heart failure due to dilated cardiomyopathy. J Heart Lung Transplant. 2005;24:1957–1964.

    Article  PubMed  Google Scholar 

  107. McGee EC Jr, Grady KL, McCarthy PM. Nontransplant surgical alternatives for heart failure. Curr Treat Options Cardiovasc Med. 2005;7:491–501.

    Article  PubMed  Google Scholar 

  108. Jones R, Lee K, Mark D, Bonw R. STICH trial. TS. Available at: http://www.stichtrial.org

  109. Athanasuleas CL, Buckberg GD, Stanley AW, et al. Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation. J Am Coll Cardiol. 2004;44:1439–1445.

    Article  PubMed  Google Scholar 

  110. Yotsumoto G, Sakata R, Ueno T, et al. Late development of mitral regurgitation after left ventricular reconstruction surgery. Ann Thorac Cardiovasc Surg. 2005;11:159–163.

    PubMed  Google Scholar 

  111. Dor V. The endoventricular circular patch plasty (“Dor procedure”) in ischemic akinetic dilated ventricles. Heart Fail Rev. 2001;6:187–193.

    Article  PubMed  CAS  Google Scholar 

  112. Cherniavsky AM, Karaskov AM, Marchenko AV, Mikova NV. Preoperative modeling of an optimal left ventricle volume for surgical treatment of ventricular aneurysms. Eur J Cardiothorac Surg. 2001;20:777–782.

    Google Scholar 

  113. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001;345:1435–1443.

    Article  PubMed  CAS  Google Scholar 

  114. Shapiro GC, Leibowitz DW, Oz MC, Weslow RG, Di Tullio MR, Homma S. Diagnosis of patent foramen ovale with transesophageal echocardiography in a patient supported with a left ventricular assist device. J Heart Lung Transplant. 1995;14:594–597.

    PubMed  CAS  Google Scholar 

  115. Reilly MP, Wiegers SE, Cucchiara AJ, et al. Frequency, risk factors, and clinical outcomes of left ventricular assist device-associated ventricular thrombus. Am J Cardiol. 2000;86: 1156–1159, A10.

    Article  PubMed  CAS  Google Scholar 

  116. Horton SC, Khodaverdian R, Chatelain P, et al. Left ventricular assist device malfunction: an approach to diagnosis by echocardiography. J Am Coll Cardiol. 2005;45: 1435–1440.

    Article  PubMed  Google Scholar 

  117. Gulati VK, Katz WE, Follansbee WP, Gorcsan J, 3rd. Mitral annular descent velocity by tissue Doppler echocardiography as an index of global left ventricular function. Am J Cardiol. 1996;77:979–984.

    Article  PubMed  CAS  Google Scholar 

  118. Yip G, Wang M, Zhang Y, Fung JW, Ho PY, Sanderson JE. Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: time for a redefinition? Heart. 2002;87:121–125.

    Article  PubMed  CAS  Google Scholar 

  119. Yu CM, Lin H, Yang H, Kong SL, Zhang Q, Lee SW. Progression of systolic abnormalities in patients with “isolated” diastolic heart failure and diastolic dysfunction. Circulation. 2002;105:1195–1201.

    Article  PubMed  Google Scholar 

  120. Wang M, Yip GW, Wang AY, et al. Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value. J Am Coll Cardiol. 2003;41:820–826.

    Article  PubMed  Google Scholar 

  121. Troughton RW, Prior DL, Frampton CM, et al. Usefulness of tissue Doppler and color M-mode indexes of left ventricular diastolic function in predicting outcomes in systolic left ventricular heart failure (from the ADEPT study). Am J Cardiol. 2005;96:257–262.

    Article  PubMed  Google Scholar 

  122. Okura H, Takada Y, Kubo T, et al. Tissue Doppler-derived index of left ventricular filling pressure, E/E′, predicts survival of patients with non-valvular atrial fibrillation. Heart. 2006;92:1248–1252.

    Article  PubMed  CAS  Google Scholar 

  123. Sun JP, Popovic ZB, Greenberg NL, et al. Noninvasive quantification of regional myocardial function using Doppler-derived velocity, displacement, strain rate, and strain in healthy volunteers: effects of aging. J Am Soc Echocardiogr. 2004;17:132–138.

    Article  PubMed  Google Scholar 

  124. Koyama J, Ray-Sequin PA, Falk RH. Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation. 2003;107:2446–2452.

    Article  PubMed  Google Scholar 

  125. Palka P, Lange A, Donnelly JE, Nihoyannopoulos P. Differentiation between restrictive cardiomyopathy and constrictive pericarditis by early diastolic Doppler myocardial velocity gradient at the posterior wall. Circulation. 2000;102:655–662.

    PubMed  CAS  Google Scholar 

  126. Bax JJ, Bleeker GB, Marwick TH, et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol. 2004;44:1834–1840.

    Article  PubMed  Google Scholar 

  127. Bax JJ, Abraham T, Barold SS, et al. Cardiac resynchronization therapy: part 1 – issues before device implantation. J Am Coll Cardiol. 2005;46:2153–2167.

    Article  PubMed  Google Scholar 

  128. Sogaard P, Egeblad H, Pedersen AK, et al. Sequential versus simultaneous biventricular resynchronization for severe heart failure: evaluation by tissue Doppler imaging. Circulation. 2002;106:2078–2084.

    Article  PubMed  Google Scholar 

  129. Helle-Valle T, Crosby J, Edvardsen T, et al. New noninvasive method for assessment of left ventricular rotation: speckle tracking echocardiography. Circulation. 2005;112:3149–3156.

    Article  PubMed  Google Scholar 

  130. Notomi Y, Lysyansky P, Setser RM, et al. Measurement of ventricular torsion by two-dimensional ultrasound speckle tracking imaging. J Am Coll Cardiol. 2005;45:2034–2041.

    Article  PubMed  Google Scholar 

  131. Knudtson ML, Galbraith PD, Hildebrand KL, Tyberg JV, Beyar R. Dynamics of left ventricular apex rotation during angioplasty: a sensitive index of ischemic dysfunction. Circulation. 1997;96:801–808.

    PubMed  CAS  Google Scholar 

  132. Stuber M, Scheidegger MB, Fischer SE, et al. Alterations in the local myocardial motion pattern in patients suffering from pressure overload due to aortic stenosis. Circulation. 1999;100:361–368.

    PubMed  CAS  Google Scholar 

  133. Vannan MA, Pedrizzetti G, Li P, et al. Effect of cardiac resynchronization therapy on longitudinal and circumferential left ventricular mechanics by velocity vector imaging: description and initial clinical application of a novel method using high-frame rate B-mode echocardiographic images. Echocardiography. 2005;22:826–830.

    Article  PubMed  Google Scholar 

  134. Fuchs E, Muller MF, Oswald H, Thony H, Mohacsi P, Hess OM. Cardiac rotation and relaxation in patients with chronic heart failure. Eur J Heart Fail. 2004;6:715–722.

    Article  PubMed  Google Scholar 

  135. Sugeng L, Weinert L, Lang RM. Left ventricular assessment using real time three dimensional echocardiography. Heart. 2003;89(suppl 3):iii29–iii36.

    PubMed  Google Scholar 

  136. Jenkins C, Bricknell K, Hanekom L, Marwick TH. Reproducibility and accuracy of echocardiographic measurements of left ventricular parameters using real-time three-dimensional echocardiography. J Am Coll Cardiol. 2004;44:878–886.

    Article  PubMed  Google Scholar 

  137. Sugeng L, Mor-Avi V, Weinert L, et al. Quantitative assessment of left ventricular size and function: side-by-side comparison of real-time three-dimensional echocardiography and computed tomography with magnetic resonance reference. Circulation. 2006;114: 654–661.

    Article  PubMed  Google Scholar 

  138. Corsi C, Lang RM, Veronesi F, et al. Volumetric quantification of global and regional left ventricular function from real-time three-dimensional echocardiographic images. Circulation. 2005;112:1161–1170.

    Article  PubMed  Google Scholar 

  139. Mor-Avi V, Sugeng L, Weinert L, et al. Fast measurement of left ventricular mass with real-time three-dimensional echocardiography: comparison with magnetic resonance imaging. Circulation. 2004;110:1814–1818.

    Article  PubMed  Google Scholar 

  140. Sugeng L, Spencer KT, Mor-Avi V, et al. Dynamic three-dimensional color flow Doppler: an improved technique for the assessment of mitral regurgitation. Echocardiography. 2003;20:265–273.

    Article  PubMed  Google Scholar 

  141. Lang RM, Mor-Avi V, Sugeng L, Nieman PS, Sahn DJ. Three-dimensional echocardiography: the benefits of the additional dimension. J Am Coll Cardiol. 2006;48:2053–2069.

    Article  PubMed  Google Scholar 

  142. Senni M, Rodeheffer RJ, Tribouilloy CM, et al. Use of echocardiography in the management of congestive heart failure in the community. J Am Coll Cardiol. 1999;33:164–170.

    Article  PubMed  CAS  Google Scholar 

  143. Kermani M, Dua A, Gradman AH. Underutilization and clinical benefits of angiotensin-converting enzyme inhibitors in patients with asymptomatic left ventricular dysfunction. Am J Cardiol. 2000;86:644–648.

    Article  PubMed  CAS  Google Scholar 

  144. Get with the Guidelines AHA. Available at: http://www.americanheart.org/presenter.jhtml?identifier=3027533

  145. Guidelines Applied in Practice ACoC. Available at: http://www.acc.org/qualityandscience/gap/or/oregon_gap.htm

  146. Nagueh SF, Zoghbi WA. Clinical assessment of LV diastolic filling by Doppler echocardiography. ACC Curr J Rev. July/August 2001;10:45–49.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiology, St Luke’s-Roosevelt Hospital Center, New York, NY, USA

    Ajay S. Shah

  2. Medicine, St Luke’s-Roosevelt Hospital Center, New York, NY, USA

    Farooq A. Chaudhry

  3. Resident Internal Medicine, St. Luke’s Roosevelt Hospital, College of Physician and Surgeons, Columbia University, New York, NY, USA

    Rawa Sarji

  4. Resident Internal Medicine, Abington Memorial Hospital, Abington, Pennsylvania

    Bilal Ayub

Authors
  1. Ajay S. Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Farooq A. Chaudhry
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rawa Sarji
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bilal Ayub
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ajay S. Shah .

Editor information

Editors and Affiliations

  1. Division of Cardiology, St. Luke's Roosevelt Hospital Center, Amsterdam Ave. 1111 , New York, 10025, U.S.A.

    Eyal Herzog

  2. Division of Cardiology, St. Luke's Roosevelt Hospital Center, Amsterdam Ave. 1111 , New York, 10025, U.S.A.

    Farooq Chaudhry

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag London Limited

About this chapter

Cite this chapter

Shah, A.S., Chaudhry, F.A., Sarji, R., Ayub, B. (2009). Echocardiography for the Management of End Stage Ischemic Heart Disease and as a Tool for Resynchronization Therapy. In: Herzog, E., Chaudhry, F. (eds) Echocardiography in Acute Coronary Syndrome. Springer, London. https://doi.org/10.1007/978-1-84882-027-2_26

Download citation

  • DOI: https://doi.org/10.1007/978-1-84882-027-2_26

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84882-026-5

  • Online ISBN: 978-1-84882-027-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation